Therefore, the antagonistic action of IST may alleviate these mood disorders in patients with PD by modulating the function of adenosine A2A receptors in the nucleus accumbens and other structures, as suggested previously [9,22]. This evidence concerns the gene ADORA2A and Parkinson disease.